SCHEMBL12705397

SCHEMBL12705397

CC(C)Oc1cc(C2CCNCC2)ccc1N

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
QDPR P09417 1/20 0.44
HTR2C P28335 4/20 0.43
CHEK1 O14757 1/20 0.43
JAK2 O60674 2/20 0.40
TLR9 Q9NR96 7/20 0.40
TLR8 Q9NR97 7/20 0.40
TLR7 Q9NYK1 7/20 0.40
ALK Q9UM73 3/20 0.40
INSR P06213 1/20 0.40
KCNH2 Q12809 1/20 0.40
PDE4B Q07343 1/20 0.40
SLC18A3 Q16572 1/20 0.39
SIGMAR1 Q99720 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL310290 0.84 HTR2C (0.55) QDPRHTR2CCHEK1TLR9TLR7
Hydrochloric Acid SCHEMBL3319085 0.83 HTR2C (0.56) QDPRHTR2CCHEK1TLR9TLR7
SCHEMBL12705532 0.81 PDE4A (0.48) PDE4B
SCHEMBL12705251 0.81 QDPR (0.52) QDPRCHEK1TLR9TLR8TLR7
SCHEMBL17580522 0.80 CCR5 (0.39) QDPRCHEK1TLR9TLR8TLR7
SCHEMBL5584880 0.79 SLC6A4 (0.45) QDPRHTR2CJAK2TLR9TLR8
SCHEMBL17580368 0.79 ADRA1D (0.39) QDPRTLR9TLR8TLR7SLC18A3
SCHEMBL17580465 0.78 POLB (0.33) HTR2CCHEK1TLR8
Tert-Butyl Formate SCHEMBL28107870 0.77 TLR7 (0.39) QDPRHTR2CJAK2TLR9TLR8
SCHEMBL17304068 0.76 POLB (0.42) TLR8PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2537830-A1 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2012-12-26 EP disclosed
EP-2311807-A1 Compounds and composition as protein kinase inhibitors IRM LLC (BM) 2011-04-20 EP disclosed
WO-2008073687-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2008-06-19 WO disclosed